Skip to content
Recall Observatory FDA recall evidence

Drug product

Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.

D-0434-2023

March 01, 2023

Class II

Product summary

Firm
B. Braun Medical Inc
Event
Event 91769
Status
Terminated
Classification
Class II
Quantity
30672
Official record key
drug-enforcement:D-0434-2023

Official wording

Reason: Subpotent Drug: low Anti-Factor IIa potency.

Code information: Lot J2C017; Expiration: 9/30/2023.

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent